Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01536223
What this trial is testing

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

Who this might be right for
ChemoradiationNasopharyngeal Carcinoma
Zhejiang Cancer Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT06770270
What this trial is testing

Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

Who this might be right for
Rectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 68
Not applicableNot Yet RecruitingNCT07258797
What this trial is testing

Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Adenocarcinoma of the Rectum
Rajiv Gandhi Cancer Institute & Research Center, India 150
Testing effectiveness (Phase 2)Ended earlyNCT01613469
What this trial is testing

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

Who this might be right for
Rectal Neoplasms
Marks, John, M.D. 5
Testing effectiveness (Phase 2)Looking for participantsNCT06394570
What this trial is testing

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Texas Southwestern Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06864013
What this trial is testing

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Zhejiang University 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07254858
What this trial is testing

Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer

Who this might be right for
HR+/HER2- Breast Cancer
First Affiliated Hospital of Wenzhou Medical University 302
Not applicableWithdrawnNCT04069910
What this trial is testing

Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases

Who this might be right for
Malignant Neoplasm, BrainBrain Tumor
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04506008
What this trial is testing

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcomas
Vanderbilt-Ingram Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06353685
What this trial is testing

De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.

Who this might be right for
De-escalated Radiotherapy; Head and Neck Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 103
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Early research (Phase 1)Study completedNCT02946008
What this trial is testing

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 17
Not applicableStudy completedNCT03368625
What this trial is testing

Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases

Who this might be right for
Brain Metastases
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509424
What this trial is testing

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Not applicableStudy completedNCT03076333
What this trial is testing

PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas

Who this might be right for
Sarcoma
UNC Lineberger Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06718309
What this trial is testing

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
First People's Hospital of Hangzhou 40
Large-scale testing (Phase 3)Looking for participantsNCT05367206
What this trial is testing

Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

Who this might be right for
Cervical CancerNeoadjuvant ChemotherapyBulky Neoplasm
Sun Yat-sen University 280
Early research (Phase 1)Ended earlyNCT03300544
What this trial is testing

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectal Adenocarcinoma+7 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)UnknownNCT03729687
What this trial is testing

Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Uppsala University 280
Next Page